Emergent BioSolutions Inc. Common Stock (EBS)
5.7850
-0.0950 (-1.62%)
NYSE · Last Trade: May 14th, 1:50 PM EDT
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via Chartmill · May 8, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via Chartmill · May 8, 2025

Via Benzinga · January 21, 2025
Via Benzinga · May 8, 2025
Via Benzinga · May 7, 2025
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · April 15, 2025
Via Benzinga · March 21, 2025

EBS earnings call for the period ending December 31, 2024.
Via The Motley Fool · March 4, 2025

For the first quarter, Emergent forecasted revenue in the range of $200 million to $240 million, lower than an analyst estimate of $279 million.
Via Stocktwits · March 4, 2025

U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions.
Via Benzinga · March 4, 2025

Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · March 3, 2025

Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%, down from 50.9% in January.
Via Benzinga · March 3, 2025

Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA)
Via Benzinga · February 28, 2025

Via Benzinga · February 12, 2025

Via Benzinga · December 30, 2024

Via Benzinga · December 30, 2024

Via Benzinga · December 30, 2024

UN calls for evidence-based, human rights-focused approach to drug policies, declaring the failed war on drugs needs to be abandoned. Urges transformative change and adoption of International Guidelines on Human Rights and Drug Policy.
Via Benzinga · December 9, 2024